iTeos Therapeutics, Inc. (ITOS) Financials

ITOS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 667.6 million 92.4 million
2023-09-30 677.6 million 79.4 million
2023-06-30 703.7 million 80.2 million
2023-03-31 728.3 million 76.1 million

ITOS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -15.2 million 7.2 million
2023-09-30 -34.6 million 7.1 million
2023-06-30 -30.2 million 7.0 million
2023-03-31 -26.7 million 5.8 million

ITOS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -30.6 million
2023-09-30 -32.2 million
2023-06-30 -34.3 million
2023-03-31 -15.6 million

ITOS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 531.9 million - 6.1 million
2023-09-30 599.0 million - 5.9 million
2023-06-30 599.2 million - 5.4 million
2023-03-31 602.1 million - 4.6 million

ITOS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 35.8 million
2023-09-30 35.8 million
2023-06-30 35.8 million
2023-03-31 35.7 million

ITOS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.4 million 27.8 million 12.4 million -
2023-09-30 751000 30.6 million 12.6 million -
2023-06-30 700000 29.2 million 13.4 million -
2023-03-31 119000 25.6 million 11.9 million -

ITOS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 233000
2023-09-30 - 224000
2023-06-30 - 198000
2023-03-31 12.6 million 224000

ITOS

Price: $11.66

52 week price:
8.20
18.24

Earnings Per Share: -3.15 USD

P/E Ratio: -5.75

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 231111

Market Capitalization: 397.9 million

Links: